Breaking News! | The FH Foundation

New FH Foundation research published today reveals that adults with familial hypercholesterolemia (FH) were able to lower their cholesterol under specialty FH care, but many are still not meeting LDL-cholesterol targets. These individuals still had high heart attack, stroke, and vascular procedure rates. In fact, this study reinforces that individuals without known heart disease may actually have a risk of heart attack that is comparable to the risk in individuals who have already had a heart attack. Intensifying Treatment and Multiple Therapies Help! Most individuals with FH will require multiple medications to adequately lower the LDL-cholesterol level to below goal. In fact, the results highlighted the broad number of treatments that are now available for FH and the benefit individuals received by being on multiple therapies. The majority of patients are on three to six treatments to lower their LDL-C. The CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia (CASCADE FH) Registry is a national multi-institution observational study that includes the largest cohort of individuals with FH in the United States. The FH Foundation established and maintains the CASCADE FH Registry to collect long-term data to help better understand outcomes of FH diagnosis and treatment.

The Atherosclerosis paper is available free through Open Access.    READ MANUSCRIPT

Check out our new infographic with key findings from the paper! DOWNLOAD INFOGRAPHIC

Read more about the study in our press release. LEARN MORE